Cargando…
Interobserver Reproducibility of PD-L1 Biomarker in Non-small Cell Lung Cancer: A Multi-Institutional Study by 27 Pathologists
BACKGROUND: Assessment of programmed cell death-ligand 1 (PD-L1) immunohistochemical staining is used for treatment decisions in non-small cell lung cancer (NSCLC) regarding use of PD-L1/programmed cell death protein 1 (PD-1) immunotherapy. The reliability of the PD-L1 22C3 pharmDx assay is critical...
Autores principales: | Chang, Sunhee, Park, Hyung Kyu, Choi, Yoon-La, Jang, Se Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Pathologists and the Korean Society for Cytopathology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877442/ https://www.ncbi.nlm.nih.gov/pubmed/31656061 http://dx.doi.org/10.4132/jptm.2019.09.29 |
Ejemplares similares
-
Usefulness of BRAF VE1 immunohistochemistry in non–small cell lung cancers: a multi-institutional study by 15 pathologists in Korea
por: Chang, Sunhee, et al.
Publicado: (2022) -
Multi-Institutional Evaluation of Pathologists’ Assessment Compared to Immunoscore
por: Willis, Joseph, et al.
Publicado: (2023) -
Interobserver Variation in the Diagnosis of Gastric Epithelial Dysplasia and Carcinoma between Two Pathologists in Japan and Korea
por: Kushima, Ryoji, et al.
Publicado: (2011) -
Interobserver reproducibility of radiographic evaluation of lumbar spine instability
por: Segundo, Saulo de Tarso de Sá Pereira, et al.
Publicado: (2016) -
Interobserver reproducibility of The Paris System for Reporting Urinary Cytology
por: Long, Theresa, et al.
Publicado: (2017)